Drug Profile
Ferrocin A
Latest Information Update: 13 Oct 2000
Price :
$50
*
At a glance
- Originator Takeda
- Class Antibacterials; Peptide antibiotics
- Mechanism of Action Chelating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 13 Oct 2000 Discontinued-Preclinical for Bacterial infections in Japan (SC)
- 12 Jun 2000 No-Development-Reported for Bacterial infections in Japan (SC)